VC
Vivo Capital Portfolio holdings
AUM $977M
1-Year Return
209.68%
This Quarter Return
+19.66%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$755M
AUM Growth
-$138M
(-15%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-24.12%
Top 10 Holdings %
Top 10 Hldgs %
75.28%
Holding
43
New
3
Increased
4
Reduced
7
Closed
3
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
+$8.14M |
| 2 |
CMPS
Compass Pathways
CMPS
|
+$5.02M |
| 3 |
Oric Pharmaceuticals
ORIC
|
+$4.48M |
| 4 |
Surrozen
SRZN
|
+$3.03M |
| 5 |
89bio
ETNB
|
+$2.74M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$131M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$53.7M |
| 3 |
Delcath Systems
DCTH
|
+$12.2M |
| 4 |
RGLS
Regulus Therapeutics
RGLS
|
+$4.03M |
| 5 |
Rezolute
RZLT
|
+$1.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$2.64B
| $319M | 42.19% |
4,458,294
-1,833,557
| -29% | -$131M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.2B
| $91.3M | 12.1% |
1,438,785
-845,190
| -37% | -$53.7M |
|
3
Geron
GERN
$798M
| $43.3M | 5.73% |
27,225,292
| – | – |
|
4
Trevi Therapeutics
TRVI
$982M
| $21.9M | 2.91% |
3,487,903
| – | – |
|
|
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.47B
| $21M | 2.78% |
2,684,109
| – | – |
|
6
Terns Pharmaceuticals
TERN
$639M
| $19M | 2.52% |
6,895,746
| – | – |
|
7
Cidara Therapeutics
CDTX
$1.64B
| $14.7M | 1.95% |
684,276
+13,676
| +2% | +$295K |
|
8
Aclaris Therapeutics
ACRS
$199M
| $13.6M | 1.8% |
8,888,888
| – | – |
|
9
Viridian Therapeutics
VRDN
$1.52B
| $13.2M | 1.75% |
982,576
| – | – |
|
10
Dyne Therapeutics
DYN
$1.85B
| $11.7M | 1.54% |
1,114,960
| – | – |
|
|
11
Oric Pharmaceuticals
ORIC
$1.06B
| $11.6M | 1.54% |
2,080,450
+802,632
| +63% | +$4.48M |
|
12
Instil Bio
TIL
$174M
| $10.2M | 1.35% |
585,485
| – | – |
|
|
CMPS
13
Compass Pathways
CMPS
$489M
| $9.62M | 1.27% |
3,362,385
+1,754,385
| +109% | +$5.02M |
|
|
14
Delcath Systems
DCTH
$385M
| $9.55M | 1.26% |
750,195
-958,384
| -56% | -$12.2M |
|
|
ZBIO
15
Zenas BioPharma, Inc. Common Stock
ZBIO
$924M
| $9.35M | 1.24% |
1,183,260
| – | – |
|
16
Verastem
VSTM
$562M
| $9.28M | 1.23% |
1,538,461
| – | – |
|
17
Erasca
ERAS
$454M
| $9.26M | 1.23% |
6,756,756
| – | – |
|
|
DRUG
18
Bright Minds Biosciences
DRUG
$345M
| $9.07M | 1.2% |
251,572
| – | – |
|
19
Tourmaline Bio
TRML
$1.22B
| $9M | 1.19% |
591,882
| – | – |
|
20
Abeona Therapeutics
ABEO
$291M
| $8.77M | 1.16% |
1,842,751
| – | – |
|
21
Astria Therapeutics
ATXS
$410M
| $8.29M | 1.1% |
1,552,685
| – | – |
|
|
22
Akero Therapeutics
AKRO
$3.41B
| $8.14M | 1.08% |
+201,168
| New | +$8.14M |
|
23
Corvus Pharmaceuticals
CRVS
$428M
| $7.11M | 0.94% |
2,234,566
| – | – |
|
24
Compass Therapeutics
CMPX
$633M
| $6.76M | 0.89% |
3,556,023
| – | – |
|
25
IO Biotech
IOBT
$113M
| $6.73M | 0.89% |
6,173,439
| – | – |
|